Who has invested in EpimAb Biotherapeutics?

Oriza Seed Capital, Decheng Capital, 3D Bioventures, Cventures, Adrian Cheng, Cormorant Asset Management are named among the investors backing EpimAb Biotherapeutics.

EpimAb Biotherapeutics Funding: $219M Raised, Series C

EpimAb Biotherapeutics funding overview

EpimAb Biotherapeutics is based in China. EpimAb Biotherapeutics has raised $219M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in March 2021. The round record for EpimAb Biotherapeutics runs through 2021; nothing later has been disclosed. Investors on record include Oriza Seed Capital, Decheng Capital, 3D Bioventures, Cventures, Adrian Cheng, Cormorant Asset Management and 9 others. 15 distinct backers are named across the disclosed rounds.

EpimAb Biotherapeutics at a glance

Total raised: $219M
Latest round: Series C
Latest round date: March 2021
Headquarters: China
Notable investors: Oriza Seed Capital, Decheng Capital, 3D Bioventures, Cventures, Adrian Cheng, Cormorant Asset Management, Hidragon Capital, Hony Capital

Frequently asked about EpimAb Biotherapeutics funding

How much has EpimAb Biotherapeutics raised?: EpimAb Biotherapeutics has raised $219M in total disclosed funding across the rounds on record.
Who has invested in EpimAb Biotherapeutics?: Oriza Seed Capital, Decheng Capital, 3D Bioventures, Cventures, Adrian Cheng, Cormorant Asset Management are named among the investors backing EpimAb Biotherapeutics.
What was the latest EpimAb Biotherapeutics funding round?: The most recent disclosed round is a Series C, announced in March 2021.
Where is EpimAb Biotherapeutics based?: EpimAb Biotherapeutics is based in China.
When did EpimAb Biotherapeutics last raise?: The last disclosed EpimAb Biotherapeutics round closed in March 2021 at Series C.

Round data for EpimAb Biotherapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in China and backer lists below.

EpimAb Biotherapeutics Funding: $219M Raised, Series C

EpimAb Biotherapeutics funding overview

EpimAb Biotherapeutics at a glance

Frequently asked about EpimAb Biotherapeutics funding

Companies related to EpimAb Biotherapeutics (18)

Browse related funding lists (5)